Cerebral activation of mitogen-activated protein kinases after circulatory arrest and low flow cardiopulmonary bypass

European Journal of Cardio-thoracic Surgery

Volumn 26, Issue 5, 2004, Pages 912-919

  Aharon, Alon S ^a   Mulloy, Matthew R ^b   Drinkwater Jr , Davis C ^b   Lao, Oliver B ^b   Johnson, Mahlon D ^b   Thunder, Megan ^b   Yu, Chang ^b   Chang, Paul ^b  

^a SAINT LOUIS UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain; Cerebral ischemia; Reperfusion; Signal transduction

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

BRAIN BLOOD VESSEL; CARDIOPULMONARY BYPASS; CEREBELLUM; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM LESION; ENZYME ACTIVATION; HEART ARREST; HYPOTHERMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MESENCEPHALON; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; BRAIN ISCHEMIA; CARDIOPULMONARY BYPASS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HEART ARREST, INDUCED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SWINE;

EID: 7244227892     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2004.05.040     Document Type: Conference Paper

References (20)

1. Goldberg C.S., Schwartz E.M., Brunberg J.A., Mosca R.S., Bove E.L., Schork M.A., Stetz S.P., Cheatham J.P., Kulik T.J. Neurodevelopmental outcome of patients after the fontan operation: a comparison between children with hypoplastic left heart syndrome and other functional single ventricle lesions. J Pediatr. 137:(5):2000;646-652
2. Mahle W.T., Spray T.L., Wernovsky G., Gaynor J.W., Clark B.J. 3rd. Survival after reconstructive surgery for hypoplastic left heart syndrome: a 15-year experience from a single institution. Circulation. 102:(19 suppl 3):2000;III136-III134
3. Bogoyevitch M.A. Signaling via stress-activated mitogen-activated protein kinases in the cardiovascular system. Cardiovasc Res. 45:2000;826-842
4. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 268:(20):1993;14553-14556
5. Pearson G., Robinson F., Gibson T.B., Xu B., Karandikar M., Berman K., Cobb M. Mitogen-Activated Protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 22:2001;153-183
6. Schimizu N., Yoshiyama M., Omura T., Hanatani A., Kim S., Takeuchi K., Iwao H., Yoshikawa J. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats. Cardiovasc Res. 38:1998;116-124
7. Chang L., Karin M. Mammalian MAP kinase signaling cascades. Nature. 410:2001;37-40
8. Bendinelli P., Piccoletti R., Maroni P., Bernelli-Zazzera A. The MAP kinase cascades are activated during post-ischemic liver reperfusion. FEBS Lett. 398:1996;193-197
9. Namura S., Iihara K., Takami S., Nagata I., Kikuchi H., Matsushita K., Moskowitz M., Bonventre J., Alessandrini A. Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc Natl Acad Sci. 98:2001;11569-11574
10. Boyle E.M., Pohlman T.H., Johnson M.C., Verrier E.D. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg. 63:1997;277-284
11. Wagerle L.C., Russo P., Dahdah N.S., Kapadia N., Davis D. Endothelial dysfunction in cerebral microcirculation during hypothermic cardiopulmonary bypass in newborn lambs. J Thorac Cardiovasc Surg. 115:1998;1047-1054
12. Lin M.T., Kao T.Y., Jin Y.T., Chen C.F. Interleukin-1 receptor antagonist attenuates the heat stroke-induced neuronal damage by reducing the cerebral ischemia in rats. Brain Res Bull. 37:1995;595-598
13. Wu D., Ye W., Che X., Yang G. Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain. J Cereb Blood Flow Metab. 20:(9):2000;1320-1330
14. Pulsinelli W.A., Brierley J.B., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol. 11:1982;491-498
15. Pombo C.M., Bonventre J.V., Avruch J., Woodgett J.R., Kyriakis J.M., Force T. The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem. 269:1994;26546-26551
16. Bogoyevitch M.A., Gillespie-Brown J., Ketterman A.J., Fuller S.J., Ben-Levy R., Ashworth A., Marshall C.J., Sugden P.H. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart: p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res. 79:1996;162-173
17. Mizukami Y., Yoshida K. Mitogen-activated protein kinase translocates to the nucleus during ischaemia and is activated during reperfusion. Biochem J. 323:1997;785-790
18. Talmor D., Applebaum A., Rudich A., Shapira Y., Tirosh A. Activation of mitogen-activated protein kinases in human heart during cardiopulmonary bypass. Circ Res. 86:2000;1004-1007
19. Hicks S.D., Parmele K.T., DeFranco D.B., Klann E., Callaway C.W. Hypothermia differentially increases extracellular signal-regulated kinase and stress-activated protein kinase/c-Jun terminal kinase activation in the hippocampus during reperfusion after asphyxial cardiac arrest. Neuroscience. 98:(4):2000;677-685
20. Alessandrini A., Namura S., Moskowitz M., Bonventre J. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci. 96:1999;12866-12869